Innate Pharma

IPHANasdaq France Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$207.763 M

$1.86 -2.10%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

93,719,323

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#95AlectorALEC$215.5M
#96Coherus OncologyCHRS$211.7M
#97Innate PharmaIPHA$207.8M
#98Protara TherapeuticsTARA$207.4M
#99SurrozenSRZN$194.3M

What if Innate Pharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$271,029.19

Per share 145,715× higher

Bitcoin $1.72T

$15,396.58

Per share 8,278× higher

Nvidia $5.48T

$49,058.56

Per share 26,376× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Innate Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.